Registered Rwanda · Rwanda FDA

INTELENCE-100

INTRAVIRINE

Rwanda FDA-HMP-MA-1947 TABLETS 100MG

What it does

Intravirine is used to help manage certain viral infections. It is part of a treatment plan to control these infections.

Commonly used for: HIV infection (human immunodeficiency virus), AIDS (acquired immunodeficiency syndrome)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
Rwanda FDA-HMP-MA-1947
Registration date
17/08/2024
Expiry date
16/08/2029
Status
Registered
Active ingredient
INTRAVIRINE
Dosage form
TABLETS
Strength
100MG
Pack size
120 Tablets
Therapeutic class
-
Manufacturer / MAH
Janssen-Cilag
Country of origin
ITALY
Manufacturer location
Contrada dei Cacciatori Italy, SS156, 40, 04100 Latina LT, Italy

Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:04 · updated 2026-09-21 02:30:19

Disclaimer: This information is sourced from Rwanda Food and Drugs Authority (Rwanda). Always consult a qualified healthcare professional before using any medication.

About this medicine

Intravirine is used to help manage certain viral infections. It is part of a treatment plan to control these infections.

What it treats

  • HIV infection (human immunodeficiency virus)
  • AIDS (acquired immunodeficiency syndrome)

How it works

Intravirine works by preventing the virus from multiplying in the body, helping to reduce the amount of virus present.

Who it's for

This medication is for individuals diagnosed with HIV or AIDS.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: intravirine

Intravirine is an experimental antiretroviral medication that belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs). It is primarily being studied for its potential use in the treatment of HIV infection. This drug works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of the HIV virus. By blocking this enzyme, intravirine helps to reduce the viral load in infected patients, thereby aiding in the management of HIV.

Indications

  • HIV infection
  • AIDS

Dosage

Children: Refer to established guidelines and clinical protocols for specific dosing information in children, as it is essential to consider age, weight, and clinical condition.

Adults: Refer to established guidelines and clinical protocols for specific dosing information, as it can vary based on individual patient factors and clinical settings.

Mechanism of action

Intravirine functions by binding to the reverse transcriptase enzyme of HIV, preventing it from converting viral RNA into DNA. This action inhibits viral replication, reducing the overall viral load in the body and allowing the immune system to recover and function more effectively.

Pharmacodynamics

As a non-nucleoside reverse transcriptase inhibitor, intravirine exhibits dose-dependent effects on viral replication. Its efficacy is determined by its ability to disrupt the HIV life cycle, specifically during the transcription phase where the viral RNA is converted into DNA. This results in decreased viral replication and an increase in CD4+ T-cell counts, which are critical for immune system health.

Pharmacokinetics

Intravirine is absorbed orally and undergoes extensive metabolism in the liver, primarily by cytochrome P450 enzymes. Its pharmacokinetic profile demonstrates a relatively short half-life, necessitating careful consideration of dosing schedules to maintain effective drug levels in the bloodstream. The drug's distribution is extensive, and it is known to penetrate various tissues, including the central nervous system.

Adverse effects

  • Nausea
  • Diarrhea
  • Fatigue
  • Headache
  • Rash
  • Elevated liver enzymes

Interactions

  • Rifampicin may decrease the effectiveness of intravirine
  • Concomitant use with other antiretroviral medications may require dose adjustments
  • Potential interactions with CYP450 inducers and inhibitors

Precautions

  • Monitor liver function regularly during treatment
  • Use with caution in patients with a history of hepatic impairment
  • Assess for potential drug interactions prior to initiation

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consultation with a healthcare provider is essential.

Breast-feeding

It is not known if intravirine is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

  • Oral tablets
  • Oral suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.